UNSPSC 51112704: Nedaplatin

This classification denotes a platinum compound with the molecular structure C2H2O3.PT.2H3N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 8UQ3W6JXAN chemically known as cis-diammine(glycolato-o(sup 1),o(sup 2))platinum, but more commonly known as nedaplatin, which bears US NIH Compound Identifier 72120. European Medicines Agency schedules Nedaplatin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09178MIG.

The term NEDAPLATIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 8 no. 3 1994, list 34). bears NCI CUID C61099 and UMLS ID C0093999. Most nations, for tariff and trade purposes, schedule nedaplatin under HS 28439000 and SITC 52432. SMILES: C(C(=O)[O-])[O-].N.N.[Pt+2].

UNSPSC 51112704 Nedaplatin is a Commodity code covering a platinum-based chemotherapy agent used in cancer treatment protocols. State and local governments procure this pharmaceutical through their health departments, public hospital systems, and correctional healthcare programs to support oncology services and inmate medical care. The code captures purchases of nedaplatin as a finished pharmaceutical product for direct clinical administration, typically sourced through group purchasing organizations, state pharmaceutical contracts, or cooperative purchasing vehicles that aggregate demand across multiple facilities.

The source provided contains no recent state or local contract opportunities tagged to this code, making current procurement activity under UNSPSC 51112704 difficult to characterize by issuing-body mix, geographic spread, or representative solicitation activity.